Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
NPAS2 (neuronal PAS domain protein 2) was discovered during the early development of the mouse brain and is the largest clock gene in humans. NPAS2, also known as MOP4, is a gene necessary for the body to maintain normal biological rhythms and participates in the regulation of the biological clock. It also plays an important role in many aspects such as cell growth, differentiation and apoptosis, tumor growth inhibition, and may be a new tumor suppressor gene.
Expression and Distribution of NPAS2
NPAS2 is widely expressed and distributed in humans. Studies have confirmed that NPAS2 exists not only in the earliest discovered brain, but also in almost all human tissues except testes. It is mainly distributed in the central rhythm system in the biological rhythm center. The formation of human biological rhythms depends on the normal expression of NPAS2. Studies have found that when NPAS2 is abnormally expressed, the incidence of circadian rhythm-related diseases such as hypertension, metabolic syndrome, tumors, and cardiovascular and cerebrovascular diseases may increase. Studies have suggested that abnormal expression of the circadian clock gene may be one of the risk factors for metabolic syndrome, and pointed out that NPAS2 and its isomer NPAS2-rs11541353 are related to the development of hypertension, and its allele is a protective factor for the development of hypertension.
In addition, studies have found abnormal expression of NPAS2 in tumor tissues. The high expression of NPAS2 can improve the survival rate of breast cancer patients. It is related to the prognosis of breast cancer. By extracting DNA from breast cancer tissues, TaqMan allele analysis method was used to analyze the NPAS2 genotype, and the correlation with clinical pathological results was done. It is found that the high expression of NPAS2 is closely related to the tumor-free survival and overall survival rate of patients, and it is proposed that NPAS2 is expected to become a new sensitive indicator for judging the prognosis of breast cancer. Studies have found that functional NPAS2 can improve the sensitivity of non-Hodgkin's lymphoma (NHL), and NPAS2 may become a new tumor marker for NHL. After testing more than ten other circadian clock genes, it was found that NPAS2 is the most closely related to the occurrence of prostate cancer.
Figure 1. Representation of the circadian clock network. (Yang, S., et al. 2017)
NPAS2 Regulates Biological Rhythm
The NPAS/BMAL1 heterodimer formed by NPAS2 and BMAL1, combined with the target gene promoter E-box, can regulate the expression of the other two circadian clock genes Per and Cry, and play a role in regulating the circadian clock rhythm. Therefore, NPAS2 may be a gene necessary for the body to maintain normal biological rhythms. When it is mutated or deleted, it will cause disturbances in the biological rhythm system. The homology of CLOCK and NPAS2 results in functional similarity and overlap between the two. The study found that mice lacking BMAL1 completely lost circadian rhythm, while individuals with CLOCK mutations did not show severe symptoms, which may be due to the replacement of its effect by the homologous analogue of CLOCK NPAS2.
NPAS2 and Tumors
Tumor development involves cell damage, apoptosis, DNA damage repair and other processes, and the NPAS2 gene may be related to these processes. NPAS2 can affect tumor formation and growth through tumor-related biological pathways. In addition, NPAS2 is also involved in the DNA damage repair response. NPAS2 is related to cell injury and apoptosis-related heat shock protein 90 (HSP90) and the role of polycyclic aromatic hydrocarbon (AH) receptors. The AH receptor plays the most critical role by its second bHLHPAS structure, while NPAS2 has a bHLH-PAS domain similar to that in hypoxia-inducible factor (HIF) and endothelial cell PAS domain protein (EPAS) 1. It may activate mammalian gene expression in response to hypoxia, which may be related to cell hypoxia damage and apoptosis.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.